Literature DB >> 12864886

Nephrology in China: a great mission and momentous challenge.

Shanyan Lin1.   

Abstract

Nephrological work in China started in early 60s, but it was not until the middle of the 1980s before it became an independent discipline and linked with the international nephrology community. Due to the huge population and enormous territory, nephrologists are facing a great mission and momentous challenges. Most nephrologists reside in the coastal region, which has a higher education background than most of the rest of the country. Among them, Beijing, Shanghai, Guanzhong and Nangjing are the major centers for training graduate students to conduct basic and clinical research. Renal biopsy is widely performed in China. IgA nephropathy is the leading cause among the primary causes of glomerulonephritis that are diagnosed by renal biopsy, while lupus nephritis is the most prominent among the causes of second glomerulopathy. Though diabetic nephropathy now constitutes only about 10% of the cause of secondary glomerulopathy, the rapid rise of diabetes mellitus predicts a future prominent role of this disease in managing progressive renal failure in China. Both hemodialysis and peritoneal dialysis are widely used in China, with approximately a 40 to 50% survival rate in three years. About two thirds of the end-stage renal disease (ESRD) patients received erythropoietin; however, the hematocrit levels of most cases are less ideal. A variety of sources, mainly from the government, in several big cities provide financial support for ESRD dialysis, which has already become a heavy burden to public health. About 5000 patients receive renal transplantation every year in which the organs are mainly from brain dead cadavers. Renal disease registration has been established since 1999. Controlling the high incidence of diabetes and early treatment, studying the genetic and environmental mechanisms possibly related to the high incidence of IgA nephropathy in rural areas, and establishing a nationwide network to apply guidelines for dialysis and transplantation in a fashion relevant to real situations in China are major challenges to the Chinese nephrologists.

Entities:  

Mesh:

Year:  2003        PMID: 12864886     DOI: 10.1046/j.1523-1755.63.s83.22.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  13 in total

1.  [Oral health status of patients undergoing hemodialysis: a Meta-analysis].

Authors:  Wei Xi; Hu Bo; Peng Haiyang; Liu Chang; Song Jinlin; Tang Ming
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2017-04-01

2.  Prevalence of reduced renal function among diabetic hypertensive patients.

Authors:  Waleed M Sweileh; Ansam F Sawalha; Sa'ed H Zyoud; Samah W Al-Jabi1; Nasr Y Shraim
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2008-11-20

3.  Clinical characteristics and outcomes of rural patients with ESRD in Guangxi, China: one dialysis center experience.

Authors:  Wenxin Zhang; Zhifeng Gong; Xiaomei Peng; Sheng Tang; Ming Bi; Wentan Huang
Journal:  Int Urol Nephrol       Date:  2009-07-14       Impact factor: 2.370

4.  Two-times weekly hemodialysis in China: frequency, associated patient and treatment characteristics and Quality of Life in the China Dialysis Outcomes and Practice Patterns study.

Authors:  Brian Bieber; Jiaqi Qian; Shuchi Anand; Yucheng Yan; Nan Chen; Mia Wang; Mei Wang; Li Zuo; Fan Fan Hou; Ronald L Pisoni; Bruce M Robinson; Sylvia P B Ramirez
Journal:  Nephrol Dial Transplant       Date:  2013-12-08       Impact factor: 5.992

5.  How can we achieve global equity in provision of renal replacement therapy?

Authors:  Sarah L White; Steven J Chadban; Stephen Jan; Jeremy R Chapman; Alan Cass
Journal:  Bull World Health Organ       Date:  2008-03       Impact factor: 9.408

6.  Anemia Management in the China Dialysis Outcomes and Practice Patterns Study.

Authors:  Li Zuo; Mia Wang; Fanfan Hou; Yucheng Yan; Nan Chen; Jiaqi Qian; Mei Wang; Brian Bieber; Ronald L Pisoni; Bruce M Robinson; Shuchi Anand
Journal:  Blood Purif       Date:  2016-03-31       Impact factor: 2.614

Review 7.  Comparative study of scientific publications in urology and nephrology journals originating from USA, China and Japan (2001-2010).

Authors:  Juan Li; Xian Hua Gao; Qi Bian; Zhi Yong Guo; Xiao Bin Mei; Guang Yu; Hao Wu; Xue Li Lai; Wei Chen
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

8.  Achievements and challenges in bioartificial kidney development.

Authors:  Farah Tasnim; Rensheng Deng; Min Hu; Sean Liour; Yao Li; Ming Ni; Jackie Y Ying; Daniele Zink
Journal:  Fibrogenesis Tissue Repair       Date:  2010-08-10

9.  Scientific publications in nephrology and urology journals from Chinese authors in East Asia: a 10-year survey of the literature.

Authors:  Jing Xu; Zhi-Guo Mao; Mei Kong; Liang-Hao Hu; Chao-Yang Ye; Cheng-Gang Xu; Shu Rong; Li-Jun Sun; Jun Wu; Bing Dai; Dong-Ping Chen; Yu-Xian Zhu; Yi-Xiang Zhang; Yu-Qiang Zhang; Xue-Zhi Zhao; Chang-Lin Mei
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

10.  The global nephrology workforce: emerging threats and potential solutions!

Authors:  Muhammad U Sharif; Mohamed E Elsayed; Austin G Stack
Journal:  Clin Kidney J       Date:  2015-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.